Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06278987 · ClinicalTrials.gov registry record · Phase 4
Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture
A Phase 4 study of Hip Fractures, sponsored by University of Minnesota.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06278987: Recruiting Phase 4 study of Hip Fractures, sponsored by University of Minnesota.
NCT06278987 is a Phase 4 study of Hip Fractures that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 150 participants, below the 611-participant average among 15 other Hip Fractures trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06278987, a Phase 4 study of Hip Fractures, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if patients with hip fractures who undergo cryoablation of the PENG have improved pain control 30 days from surgery when compared to those who have a fascia iliaca catheter.
Primary Outcome
Maximum pain score on day 30 post surgery. Pain Scale is 0-10 with 0 meaning no pain (better outcome) and 10 meaning worst pain imaginable (worse outcome).
Conditions Studied
Interventions
- DRUG PENG block and cryoablation
- DRUG fascia iliaca compartment block
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2027-10-01 |
| Phase | Phase 4 |
What NCT06278987 shows while recruiting
NCT06278987 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 611-participant average among 15 other Hip Fractures trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Hip Fractures appearing as the primary indexed condition, and to 2 interventions - of which PENG block and cryoablation is the first listed.
NCT06278987 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06278987 about?
NCT06278987 is a clinical study titled "Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture". The purpose of this study is to determine if patients with hip fractures who undergo cryoablation of the PENG have improved pain control 30 days from surgery when compared to those who have a fascia iliaca catheter.
What is the current status of trial NCT06278987?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2024-10-01. Estimated completion is 2027-10-01.
What conditions does trial NCT06278987 study?
This clinical trial studies the following conditions: Hip Fractures.
What interventions are being tested in trial NCT06278987?
The interventions under investigation include: PENG block and cryoablation (DRUG), fascia iliaca compartment block (DRUG).
Who is sponsoring clinical trial NCT06278987?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06278987 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06278987's enrollment target sits among peer trials
150 12th of 15 higher than 4 of 15 other Hip Fractures trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hip Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion
RECRUITING · Phase 4
-
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
RECRUITING · NA
-
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
RECRUITING · NA
-
Cervical Myelopathy in Hip Fracture Patients
RECRUITING · NA
-
PENG vs Femoral Block for Hip Fracture Analgesia
RECRUITING · NA
-
MDR - PMCF Study for Taperloc Complete Stems
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI